Close Menu
    Facebook X (Twitter) Instagram
    Latest
    • A new malpractice being observed: Reviewers asking their own papers to cite
    • 100% APC Waiver for Authors from “Group A” Category Countries Indicated by Research4Life
    • Retraction Notice: Pharmacological Actions of Impatiens
    • DOI Allocated and Activated for 281 Articles and Abstracts Published in the period of 2014-2017
    • IGJPS, 2021, Vol 11, Issue 3
    • IGJPS, 2021, Vol 11, Issue 2
    • IGJPS, 2021, Vol 11, Issue 1
    • Table of Contents, Vol 10, Issue 4
    INDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCESINDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCES
    • Home
    • About Us
    • Issues
      • IGJPS 2022 and Onwards
      • IGJPS, 2021, Vol 11, Issue 3
      • IGJPS, 2021, Vol 11, Issue 2
      • IGJPS, 2021, Vol 11, Issue 1
      • IGJPS, 2020, Vol 10, Issue 4
      • IGJPS, 2020, Vol 10, Issue 3
      • IGJPS, 2020, Vol 10, Issue 2
      • IGJPS, 2020, Vol 10, Issue 1
      • IGJPS, 2019, Vol 9, Issue 2 (Suppl.)
      • IGJPS, 2019, Vol 9, Issue 2
      • IGJPS, 2019, Vol 9, Issue 1
      • IGJPS, 2018, Vol 8, Issue 3
      • IGJPS, 2018, Vol 8, Issue 2
      • IGJPS, 2018, Vol 8, Issue 1
      • IGJPS, 2017, Vol 7, Issue 2
      • IGJPS, 2017, Vol 7, Issue 1
      • IGJPS, 2016, Vol 6, Issue 2
      • IGJPS, 2016, Vol 6, Issue 1
      • IGJPS, 2015, Vol 5, Issue 3
      • IGJPS, 2015, Vol 5, Issue 2
      • IGJPS, 2015, Vol 5, Issue 1
      • IGJPS, 2014, Vol 4, Issue 3
      • IGJPS, 2014, Vol 4, Issue 2
      • IGJPS, 2014, Vol4, Issue 1
      • IGJPS, 2013, Vol 3, Issue 3
      • IGJPS,2013, Vol 3, Issue 2
      • IGJPS, 2013, Vol 3, Issue 1
      • IGJPS, 2012, Vol 2, Issue 4
      • IGJPS, 2012, Vol 2, Issue 3
      • IGJPS, 2012, Vol 2, Issue 2
      • IGJPS, 2012, Vol 2, Issue 1
      • IGJPS, 2011, Vol 1, Issue 4
      • IGJPS, 2011, Vol 1, Issue 3
      • IGJPS, 2011, Vol 1, Issue 2
      • IGJPS, 2011, Vol 1, Issue 1
    • Editorial Board
    • Guidelines For Authors
    • Indexed
    • Manuscript Submission
    • Contact Us
    INDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCESINDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCES
    You are at:Home»News»2011 will be a year of regulatory tussle for pharmaceutical industry

    2011 will be a year of regulatory tussle for pharmaceutical industry

    0
    By Rajeev Singla on January 21, 2012 News

    Government policy and regulatory changes were the focus point for the pharmaceutical industry in India in the year 2011.

    The government actively intervened in business and sought more control in various activities from acquisition to pricing controls. While some changes were opposed others were implemented as the companies in the sector continued their business.

    Ranbaxy Laboratories was able to reach an agreement with the US FDA to revoke a ban on sale of drugs produced at some of its plants, in the US market. Lupin acquired I’rom Pharmaceutical Company in Japan and Sun Pharma proposed a complete takeover of the Israeli firm Taro.

    The government appeared concerned over the pace at which MNCs were acquiring Indian pharmaceutical firms and was concerned over the priced of drugs in the country. The government decided to have a mechanism in place and introduced checks by removing automatic approval of foreign direct investment (FDI) in existing domestic pharmaceutical companies.

    Under the new rules, any foreign investor will now have to get an approval from the Foreign Investment Promotion Board (FIPB) for all mergers or acquisitions. The decision to introduce such mechanism was taken after a directive from Prime Minister Manmohan Singh. The PM had held discussions with several of his cabinet ministers on the issue of acquisitions of domestic pharmaceutical firms by overseas firms.

     

    Source- Top News.in

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    A new malpractice being observed: Reviewers asking their own papers to cite

    100% APC Waiver for Authors from “Group A” Category Countries Indicated by Research4Life

    Retraction Notice: Pharmacological Actions of Impatiens

    Comments are closed.

    Latest News
    A new malpractice being observed: Reviewers asking their own papers to cite
    ...
    100% APC Waiver for Authors from “Group A” Category Countries Indicated by Research4Life
    ...
    Retraction Notice: Pharmacological Actions of Impatiens
    ...
    DOI Allocated and Activated for 281 Articles and Abstracts Published in the period of 2014-2017
    ...
    Top Peer Reviewer as New Associate Editor: Dr. Ghulam Md. Ashraf, King Abdulaziz University, Jeddah, Saudi Arabia
    ...
    Highly Cited Articles

    Microencapsulation–A Novel Approach in Drug Delivery: A Review

    Review on the pharmacognostical & pharmacological characterization of Apium graveolens Linn


    Medicinal Plants of Rural India: A Review of Use by Indian Folks


    Self Emulsifying Drug Delivery System: A Tool in Solubility Enhancement of Poorly Soluble Drugs


    Antioxidant and antimicrobial activities of Cocos nucifera Linn.(Arecaceae) endocarp extracts

    Impotant Links
    • About Us
    • Call For Papers
    • Contact Us
    • Editorial Board
    • For Reviewers
    • Guidelines For Authors
    • Home Page
    • Indexed
    • Issues
    • Manuscript Submission
    • Checkout
    • Transaction Results
    • Your Account
    Sponsored
    Copyright © 2011 iGlobal Research & Publishing Foundation
    Powered By :- Ganga Graphix.

    Type above and press Enter to search. Press Esc to cancel.